MedPacto, Inc.
Research MedPacto, Inc. (235980.KQ) on Bullrun: market cap KRW 107.80B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker235980.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 107.80B
- Financial periodQ2 2026
- RevenueKRW 1.05B
- Net income-KRW 3.19B
- Free cash flow-KRW 2.30B
- Gross margin5.6%
Valuation Snapshot
latest market cap is KRW 107.80B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 107.80B | n/a | n/a | n/a |
Dividend history
About MedPacto, Inc.
MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
ORIENT BIO Inc. (002630.KS)
GC Corp. (005250.KS)
Pharmicell Co., Ltd. (005690.KS)
Kanaph Therapeutics Inc. (0082N0.KQ)
Samik Pharmaceutical Company LTD. (014950.KQ)
HLB Co., Ltd. (028300)
Mgen Solutions Co., Ltd. (032790.KQ)
Daesung Microbiological Labs. Co., Ltd. (036480.KQ)
Seoulin Bioscience Co.,Ltd. (038070.KQ)
Hyundai Bioscience Co., Ltd. (048410.KQ)
iNtRON Biotechnology, Inc. (048530.KQ)
Synergy Innovation Co., Ltd. (048870.KQ)
Frequently asked questions
What is MedPacto, Inc.'s market cap?
MedPacto, Inc.'s market capitalization is KRW 107.80B.
What does MedPacto, Inc. do?
MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.